prima biomed: time to change leader, page-17

Herro, agree heartedly and like you, I believe all is well and the low sp provided me with a golden opportunity to buy more shares. But thats just me and I would never recommend to others to do the same. Everyone should do their own research and make their own investment decisions.

I think Martin has done a great job for Prima and that he will continue to use his exceptional company making skills in whatever he does in the future. He has laid the foundations and structure and now its up to the clinicians and patients. Matthew Lehman has all the attributes required to progress the companies work from this point.

Its not easy to develop and prove a product and process that combats aggressive cancers but PRR has top people working with this who believe in the product and have the runs on the board and knowledge and experience that imo merits credibility.

cheers